5,886 reports of this reaction
11.6% of all TAPENTADOL HYDROCHLORIDE reports
#3 most reported adverse reaction
OVERDOSE is the #3 most commonly reported adverse reaction for TAPENTADOL HYDROCHLORIDE, manufactured by Collegium Pharmaceutical, Inc.. There are 5,886 FDA adverse event reports linking TAPENTADOL HYDROCHLORIDE to OVERDOSE. This represents approximately 11.6% of all 50,606 adverse event reports for this drug.
TAPENTADOL HYDROCHLORIDE has an overall safety score of 92 out of 100. Patients taking TAPENTADOL HYDROCHLORIDE who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is a frequently reported adverse event for TAPENTADOL HYDROCHLORIDE, accounting for a significant proportion of all reports.
In addition to overdose, the following adverse reactions have been reported for TAPENTADOL HYDROCHLORIDE:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 5,886 FDA reports for TAPENTADOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 11.6% of all adverse event reports for TAPENTADOL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience overdose while taking TAPENTADOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.